克唑替尼 Crizotinib Crizotinib, also known as PF-02341066, is an orally bioavailable agent belonging to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors

厄洛替尼/埃羅替尼 Erlotinib Erlotinib is an epidermal growth factor receptor inhibitor (EGFR inhibitor). Erlotinib HCl was approved.

Gefitinib, also known as ZD1839, is an anilinoquinazoline with antineoplastic activity. It inhibits the catalytic activity of numerous tyrosine kinases.

阿法替尼 Afatinib Afatinib, also know as BIBW 2992, is an orally bioavailable dual receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity.

人PSA-NCAM陽性（PSA-NCAM+）神經細胞 Human neural progenitor cells (PSA-NCAM+) are derived from whole brain that are quickly dissociated into single cells and cultured.